Pre-order Enquiry
Request Free Sample
Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2021-2027
SKU ID : QYR-18335496 | Publishing Date : 24-May-2021 | No. of pages : 143
Detailed TOC of Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2021-2027
1 Report Overview1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type
1.2.2 GMP
1.2.3 Non-GMP
1.3 Market Segment by Application
1.3.1 Global Pharmaceutical Intermediates Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Pharmaceutical Intermediates Market Size (2016-2027)
2.1.1 Global Pharmaceutical Intermediates Revenue (2016-2027)
2.1.2 Global Pharmaceutical Intermediates Sales (2016-2027)
2.2 Global Pharmaceutical Intermediates Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Pharmaceutical Intermediates Sales by Regions (2016-2021)
2.2.2 Global Pharmaceutical Intermediates Revenue by Regions (2016-2021)
2.3 Global Pharmaceutical Intermediates Market Size Forecast by Region
2.3.1 Global Pharmaceutical Intermediates Sales Forecast by Region (2022-2027)
2.3.2 Global Pharmaceutical Intermediates Revenue Forecast by Region (2022-2027)
2.4 Global Top Pharmaceutical Intermediates Regions (Countries) Ranking by Market Size
2.5 Pharmaceutical Intermediates Industry Trends
2.5.1 Pharmaceutical Intermediates Market Trends
2.5.2 Pharmaceutical Intermediates Market Drivers
2.5.3 Pharmaceutical Intermediates Market Challenges
2.5.4 Pharmaceutical Intermediates Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Pharmaceutical Intermediates Manufacturers by Sales (2016-2021)
3.1.1 Global Pharmaceutical Intermediates Sales by Manufacturers (2016-2021)
3.1.2 Global Pharmaceutical Intermediates Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Pharmaceutical Intermediates Sales in 2020
3.2 Global Top Manufacturers Pharmaceutical Intermediates by Revenue
3.2.1 Global Pharmaceutical Intermediates Revenue by Manufacturers (2016-2021)
3.2.2 Top Pharmaceutical Intermediates Manufacturers Covered: Ranking by Revenue
3.2.3 Global Pharmaceutical Intermediates Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2020)
3.4 Global Pharmaceutical Intermediates Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Pharmaceutical Intermediates Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Pharmaceutical Intermediates Market
3.7 Key Manufacturers Pharmaceutical Intermediates Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Pharmaceutical Intermediates Market Size by Type
4.1 Global Pharmaceutical Intermediates Historic Market Review by Type (2016-2021)
4.1.1 Global Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
4.1.2 Global Pharmaceutical Intermediates Revenue Market Share by Type (2016-2021)
4.1.3 Pharmaceutical Intermediates Price by Type (2016-2021)
4.2 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pharmaceutical Intermediates Sales Forecast by Type (2022-2027)
4.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Type (2022-2027)
4.2.3 Pharmaceutical Intermediates Price Forecast by Type (2022-2027)
5 Global Pharmaceutical Intermediates Market Size by Application
5.1 Global Pharmaceutical Intermediates Historic Market Review by Application (2016-2021)
5.1.2 Global Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
5.1.3 Global Pharmaceutical Intermediates Revenue Market Share by Application (2016-2021)
5.1.4 Pharmaceutical Intermediates Price by Application (2016-2021)
5.2 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Application (2022-2027)
5.2.2 Global Pharmaceutical Intermediates Sales Forecast by Application (2022-2027)
5.2.3 Global Pharmaceutical Intermediates Revenue Forecast by Application (2022-2027)
5.2.4 Pharmaceutical Intermediates Price Forecast by Application (2022-2027)
6 North America
6.1 North America Pharmaceutical Intermediates Sales Breakdown by Company
6.1.1 North America Pharmaceutical Intermediates Sales by Company (2016-2027)
6.1.2 North America Pharmaceutical Intermediates Revenue by Company (2016-2027)
6.2 North America Pharmaceutical Intermediates Market Size by Type (2016-2027)
6.2.1 North America Pharmaceutical Intermediates Sales by Type (2016-2027)
6.2.2 North America Pharmaceutical Intermediates Revenue by Type (2016-2027)
6.3 North America Pharmaceutical Intermediates Market Size by Application (2016-2027)
6.3.1 North America Pharmaceutical Intermediates Sales by Application (2016-2027)
6.3.2 North America Pharmaceutical Intermediates Revenue by Application (2016-2027)
6.4 North America Pharmaceutical Intermediates Market Size by Country
6.4.1 North America Pharmaceutical Intermediates Sales by Country (2016-2027)
6.4.2 North America Pharmaceutical Intermediates Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pharmaceutical Intermediates Sales Breakdown by Company
7.1.1 Europe Pharmaceutical Intermediates Sales by Company (2016-2027)
7.1.2 Europe Pharmaceutical Intermediates Revenue by Company (2016-2027)
7.2 Europe Pharmaceutical Intermediates Market Size by Type (2016-2027)
7.2.1 Europe Pharmaceutical Intermediates Sales by Type (2016-2027)
7.2.2 Europe Pharmaceutical Intermediates Revenue by Type (2016-2027)
7.3 Europe Pharmaceutical Intermediates Market Size by Application (2016-2027)
7.3.1 Europe Pharmaceutical Intermediates Sales by Application (2016-2027)
7.3.2 Europe Pharmaceutical Intermediates Revenue by Application (2016-2027)
7.4 Europe Pharmaceutical Intermediates Market Size by Country
7.4.1 Europe Pharmaceutical Intermediates Sales by Country (2016-2027)
7.4.2 Europe Pharmaceutical Intermediates Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pharmaceutical Intermediates Sales Breakdown by Company
8.1.1 Asia Pacific Pharmaceutical Intermediates Sales by Company (2016-2027)
8.1.2 Asia Pacific Pharmaceutical Intermediates Revenue by Company (2016-2027)
8.2 Asia Pacific Pharmaceutical Intermediates Market Size by Type (2016-2027)
8.2.1 Asia Pacific Pharmaceutical Intermediates Sales by Type (2016-2027)
8.2.2 Asia Pacific Pharmaceutical Intermediates Revenue by Type (2016-2027)
8.3 Asia Pacific Pharmaceutical Intermediates Market Size by Application (2016-2027)
8.3.1 Asia Pacific Pharmaceutical Intermediates Sales by Application (2016-2027)
8.3.2 Asia Pacific Pharmaceutical Intermediates Revenue by Application (2016-2027)
8.4 Asia Pacific Pharmaceutical Intermediates Market Size by Regions
8.4.1 Asia Pacific Pharmaceutical Intermediates Sales by Regions
8.4.2 Asia Pacific Pharmaceutical Intermediates Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Pharmaceutical Intermediates Sales Breakdown by Company
9.1.1 Latin America Pharmaceutical Intermediates Sales by Company (2016-2027)
9.1.2 Latin America Pharmaceutical Intermediates Revenue by Company (2016-2027)
9.2 Latin America Pharmaceutical Intermediates Market Size by Type (2016-2027)
9.2.1 Latin America Pharmaceutical Intermediates Sales by Type (2016-2027)
9.2.2 Latin America Pharmaceutical Intermediates Revenue by Type (2016-2027)
9.3 Latin America Pharmaceutical Intermediates Market Size by Application (2016-2027)
9.3.1 Latin America Pharmaceutical Intermediates Sales by Application (2016-2027)
9.3.2 Latin America Pharmaceutical Intermediates Revenue by Application (2016-2027)
9.4 Latin America Pharmaceutical Intermediates Market Size by Country
9.4.1 Latin America Pharmaceutical Intermediates Sales by Country (2016-2027)
9.4.2 Latin America Pharmaceutical Intermediates Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pharmaceutical Intermediates Sales Breakdown by Company
10.1.1 Middle East and Africa Pharmaceutical Intermediates Sales by Company (2016-2027)
10.1.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Company (2016-2027)
10.2 Middle East and Africa Pharmaceutical Intermediates Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Pharmaceutical Intermediates Sales by Type (2016-2027)
10.2.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Type (2016-2027)
10.3 Middle East and Africa Pharmaceutical Intermediates Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Pharmaceutical Intermediates Sales by Application (2016-2027)
10.3.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2016-2027)
10.4 Middle East and Africa Pharmaceutical Intermediates Market Size by Country
10.4.1 Middle East and Africa Pharmaceutical Intermediates Sales by Country (2016-2027)
10.4.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Overview
11.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Lonza Pharmaceutical Intermediates Products and Services
11.1.5 Lonza Pharmaceutical Intermediates SWOT Analysis
11.1.6 Lonza Recent Developments
11.2 Catalent
11.2.1 Catalent Corporation Information
11.2.2 Catalent Overview
11.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Catalent Pharmaceutical Intermediates Products and Services
11.2.5 Catalent Pharmaceutical Intermediates SWOT Analysis
11.2.6 Catalent Recent Developments
11.3 Patheon
11.3.1 Patheon Corporation Information
11.3.2 Patheon Overview
11.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Patheon Pharmaceutical Intermediates Products and Services
11.3.5 Patheon Pharmaceutical Intermediates SWOT Analysis
11.3.6 Patheon Recent Developments
11.4 Jubilant
11.4.1 Jubilant Corporation Information
11.4.2 Jubilant Overview
11.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Jubilant Pharmaceutical Intermediates Products and Services
11.4.5 Jubilant Pharmaceutical Intermediates SWOT Analysis
11.4.6 Jubilant Recent Developments
11.5 Granules
11.5.1 Granules Corporation Information
11.5.2 Granules Overview
11.5.3 Granules Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Granules Pharmaceutical Intermediates Products and Services
11.5.5 Granules Pharmaceutical Intermediates SWOT Analysis
11.5.6 Granules Recent Developments
11.6 Ganesh
11.6.1 Ganesh Corporation Information
11.6.2 Ganesh Overview
11.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Ganesh Pharmaceutical Intermediates Products and Services
11.6.5 Ganesh Pharmaceutical Intermediates SWOT Analysis
11.6.6 Ganesh Recent Developments
11.7 Chemcon
11.7.1 Chemcon Corporation Information
11.7.2 Chemcon Overview
11.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Chemcon Pharmaceutical Intermediates Products and Services
11.7.5 Chemcon Pharmaceutical Intermediates SWOT Analysis
11.7.6 Chemcon Recent Developments
11.8 BASF
11.8.1 BASF Corporation Information
11.8.2 BASF Overview
11.8.3 BASF Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 BASF Pharmaceutical Intermediates Products and Services
11.8.5 BASF Pharmaceutical Intermediates SWOT Analysis
11.8.6 BASF Recent Developments
11.9 Porton
11.9.1 Porton Corporation Information
11.9.2 Porton Overview
11.9.3 Porton Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Porton Pharmaceutical Intermediates Products and Services
11.9.5 Porton Pharmaceutical Intermediates SWOT Analysis
11.9.6 Porton Recent Developments
11.10 Lianhetech
11.10.1 Lianhetech Corporation Information
11.10.2 Lianhetech Overview
11.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Lianhetech Pharmaceutical Intermediates Products and Services
11.10.5 Lianhetech Pharmaceutical Intermediates SWOT Analysis
11.10.6 Lianhetech Recent Developments
11.11 ABA Chem
11.11.1 ABA Chem Corporation Information
11.11.2 ABA Chem Overview
11.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 ABA Chem Pharmaceutical Intermediates Products and Services
11.11.5 ABA Chem Recent Developments
11.12 Tianma
11.12.1 Tianma Corporation Information
11.12.2 Tianma Overview
11.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Tianma Pharmaceutical Intermediates Products and Services
11.12.5 Tianma Recent Developments
11.13 Jiujiujiu
11.13.1 Jiujiujiu Corporation Information
11.13.2 Jiujiujiu Overview
11.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Jiujiujiu Pharmaceutical Intermediates Products and Services
11.13.5 Jiujiujiu Recent Developments
11.14 Alpha
11.14.1 Alpha Corporation Information
11.14.2 Alpha Overview
11.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 Alpha Pharmaceutical Intermediates Products and Services
11.14.5 Alpha Recent Developments
11.15 Jiuzhou
11.15.1 Jiuzhou Corporation Information
11.15.2 Jiuzhou Overview
11.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 Jiuzhou Pharmaceutical Intermediates Products and Services
11.15.5 Jiuzhou Recent Developments
11.16 Yongtai
11.16.1 Yongtai Corporation Information
11.16.2 Yongtai Overview
11.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.16.4 Yongtai Pharmaceutical Intermediates Products and Services
11.16.5 Yongtai Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pharmaceutical Intermediates Value Chain Analysis
12.2 Pharmaceutical Intermediates Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharmaceutical Intermediates Production Mode & Process
12.4 Pharmaceutical Intermediates Sales and Marketing
12.4.1 Pharmaceutical Intermediates Sales Channels
12.4.2 Pharmaceutical Intermediates Distributors
12.5 Pharmaceutical Intermediates Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2021-2027
List of TablesTable 1. Global Pharmaceutical Intermediates Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of GMP
Table 3. Major Manufacturers of Non-GMP
Table 4. Global Pharmaceutical Intermediates Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Market Pharmaceutical Intermediates Market Size (US$ Million) by Region: 2016 VS 2021 VS 2027
Table 6. Global Pharmaceutical Intermediates Sales by Region (2016-2021) & (K MT)
Table 7. Global Pharmaceutical Intermediates Sales Market Share by Region (2016-2021)
Table 8. Global Pharmaceutical Intermediates Revenue by Region (2016-2021) & (US$ Million)
Table 9. Global Pharmaceutical Intermediates Revenue Market Share by Region (2016-2021)
Table 10. Global Pharmaceutical Intermediates Sales Forecast by Region (2022-2027) & (K MT)
Table 11. Global Pharmaceutical Intermediates Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Pharmaceutical Intermediates Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Region (2022-2027)
Table 14. Top Pharmaceutical Intermediates Regions (Countries) Ranking by Market Size (US$ Million) in 2020
Table 15. Pharmaceutical Intermediates Market Trends
Table 16. Pharmaceutical Intermediates Market Drivers
Table 17. Pharmaceutical Intermediates Market Challenges
Table 18. Pharmaceutical Intermediates Market Restraints
Table 19. Global Pharmaceutical Intermediates Sales by Manufacturers (2016-2021) & (K MT)
Table 20. Global Pharmaceutical Intermediates Sales Share by Manufacturers (2016-2021)
Table 21. Global Pharmaceutical Intermediates Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 22. Ranking of Global Top Pharmaceutical Intermediates Manufacturers by Revenue (US$ Million) in 2020
Table 23. Pharmaceutical Intermediates Revenue Share by Manufacturers (2016-2021)
Table 24. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2020)
Table 26. Key Manufacturers Pharmaceutical Intermediates Average Selling Price (ASP) & (2016-2021) & (USD/MT)
Table 27. Key Manufacturers Pharmaceutical Intermediates Plants/Factories Distribution
Table 28. Key Manufacturers Pharmaceutical Intermediates Area Served
Table 29. Date of Key Manufacturers Enter into Pharmaceutical Intermediates Market
Table 30. Key Manufacturers Pharmaceutical Intermediates Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Pharmaceutical Intermediates Sales (K MT) by Type (2016-2021)
Table 33. Global Pharmaceutical Intermediates Sales Share by Type (2016-2021)
Table 34. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Type (2016-2021)
Table 35. Global Pharmaceutical Intermediates Price (K MT) by Type (2016-2021)
Table 36. Global Pharmaceutical Intermediates Sales (K MT) by Type (2022-2027)
Table 37. Global Pharmaceutical Intermediates Sales Share by Type (2022-2027)
Table 38. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Type (2022-2027)
Table 39. Global Pharmaceutical Intermediates Revenue Share by Type (2022-2027)
Table 40. Global Pharmaceutical Intermediates Price (K MT) by Type (2022-2027)
Table 41. Global Pharmaceutical Intermediates Sales (K MT) by Application (2016-2021)
Table 42. Global Pharmaceutical Intermediates Sales Share by Application (2016-2021)
Table 43. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Application (2016-2021)
Table 44. Global Pharmaceutical Intermediates Price (K MT) by Application (2016-2021)
Table 45. Global Pharmaceutical Intermediates Sales (K MT) by Application (2022-2027)
Table 46. Global Pharmaceutical Intermediates Sales Share by Application (2022-2027)
Table 47. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Application (2022-2027)
Table 48. Global Pharmaceutical Intermediates Revenue Share by Application (2022-2027)
Table 49. Global Pharmaceutical Intermediates Price (K MT) by Application (2022-2027)
Table 50. North America Pharmaceutical Intermediates Sales by Company (2016-2021) & (K MT)
Table 51. North America Pharmaceutical Intermediates Sales Market Share by Company (2016-2021)
Table 52. North America Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million)
Table 53. North America Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021)
Table 54. North America Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 55. North America Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 56. North America Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million)
Table 57. North America Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million)
Table 58. North America Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 59. North America Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 60. North America Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 63. North America Pharmaceutical Intermediates Sales by Country (2022-2027) & (K MT)
Table 64. North America Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Pharmaceutical Intermediates Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Pharmaceutical Intermediates Sales by Company (2016-2021) & (K MT)
Table 67. Europe Pharmaceutical Intermediates Sales Market Share by Company (2016-2021)
Table 68. Europe Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million)
Table 69. Europe Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021)
Table 70. Europe Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 71. Europe Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 72. Europe Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 75. Europe Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 76. Europe Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million)
Table 77. Europe Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million)
Table 78. Europe Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 79. Europe Pharmaceutical Intermediates Sales by Country (2022-2027) & (K MT)
Table 80. Europe Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Pharmaceutical Intermediates Revenue by Country (2022-2027) & (US$ Million)
Table 82. Asia Pacific Pharmaceutical Intermediates Sales by Company (2016-2021) & (K MT)
Table 83. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Company (2016-2021)
Table 84. Asia Pacific Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million)
Table 85. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021)
Table 86. Asia Pacific Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 87. Asia Pacific Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 88. Asia Pacific Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million)
Table 89. Asia Pacific Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million)
Table 90. Asia Pacific Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 91. Asia Pacific Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 92. Asia Pacific Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million)
Table 93. Asia Pacific Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million)
Table 94. Asia Pacific Pharmaceutical Intermediates Sales by Region (2016-2021) & (K MT)
Table 95. Asia Pacific Pharmaceutical Intermediates Sales by Region (2022-2027) & (K MT)
Table 96. Asia Pacific Pharmaceutical Intermediates Revenue by Region (2016-2021) & (US$ Million)
Table 97. Asia Pacific Pharmaceutical Intermediates Revenue by Region (2022-2027) & (US$ Million)
Table 98. Latin America Pharmaceutical Intermediates Sales by Company (2016-2021) & (K MT)
Table 99. Latin America Pharmaceutical Intermediates Sales Market Share by Company (2016-2021)
Table 100. Latin America Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million)
Table 101. Latin America Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021)
Table 102. Latin America Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 103. Latin America Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 104. Latin America Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million)
Table 105. Latin America Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million)
Table 106. Latin America Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 107. Latin America Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 108. Latin America Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million)
Table 109. Latin America Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million)
Table 110. Latin America Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 111. Latin America Pharmaceutical Intermediates Sales by Country (2022-2027) & (K MT)
Table 112. Latin America Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 113. Latin America Pharmaceutical Intermediates Revenue by Country (2022-2027) & (US$ Million)
Table 114. Middle East and Africa Pharmaceutical Intermediates Sales by Company (2016-2021) & (K MT)
Table 115. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Company (2016-2021)
Table 116. Middle East and Africa Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million)
Table 117. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021)
Table 118. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 119. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 120. Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million)
Table 121. Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million)
Table 122. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 123. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 124. Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million)
Table 125. Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million)
Table 126. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 127. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2022-2027) & (K MT)
Table 128. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 129. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2022-2027) & (US$ Million)
Table 130. Lonza Corporation Information
Table 131. Lonza Description and Overview
Table 132. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 133. Lonza Pharmaceutical Intermediates Product and Services
Table 134. Lonza Pharmaceutical Intermediates SWOT Analysis
Table 135. Lonza Recent Developments
Table 136. Catalent Corporation Information
Table 137. Catalent Description and Overview
Table 138. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 139. Catalent Pharmaceutical Intermediates Product and Services
Table 140. Catalent Pharmaceutical Intermediates SWOT Analysis
Table 141. Catalent Recent Developments
Table 142. Patheon Corporation Information
Table 143. Patheon Description and Overview
Table 144. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 145. Patheon Pharmaceutical Intermediates Product and Services
Table 146. Patheon Pharmaceutical Intermediates SWOT Analysis
Table 147. Patheon Recent Developments
Table 148. Jubilant Corporation Information
Table 149. Jubilant Description and Overview
Table 150. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 151. Jubilant Pharmaceutical Intermediates Product and Services
Table 152. Jubilant Pharmaceutical Intermediates SWOT Analysis
Table 153. Jubilant Recent Developments
Table 154. Granules Corporation Information
Table 155. Granules Description and Overview
Table 156. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 157. Granules Pharmaceutical Intermediates Product and Services
Table 158. Granules Pharmaceutical Intermediates SWOT Analysis
Table 159. Granules Recent Developments
Table 160. Ganesh Corporation Information
Table 161. Ganesh Description and Overview
Table 162. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 163. Ganesh Pharmaceutical Intermediates Product and Services
Table 164. Ganesh Pharmaceutical Intermediates SWOT Analysis
Table 165. Ganesh Recent Developments
Table 166. Chemcon Corporation Information
Table 167. Chemcon Description and Overview
Table 168. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 169. Chemcon Pharmaceutical Intermediates Product and Services
Table 170. Chemcon Pharmaceutical Intermediates SWOT Analysis
Table 171. Chemcon Recent Developments
Table 172. BASF Corporation Information
Table 173. BASF Description and Overview
Table 174. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 175. BASF Pharmaceutical Intermediates Product and Services
Table 176. BASF Pharmaceutical Intermediates SWOT Analysis
Table 177. BASF Recent Developments
Table 178. Porton Corporation Information
Table 179. Porton Description and Overview
Table 180. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 181. Porton Pharmaceutical Intermediates Product and Services
Table 182. Porton Pharmaceutical Intermediates SWOT Analysis
Table 183. Porton Recent Developments
Table 184. Lianhetech Corporation Information
Table 185. Lianhetech Description and Overview
Table 186. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 187. Lianhetech Pharmaceutical Intermediates Product and Services
Table 188. Lianhetech Pharmaceutical Intermediates SWOT Analysis
Table 189. Lianhetech Recent Developments
Table 190. ABA Chem Corporation Information
Table 191. ABA Chem Description and Overview
Table 192. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 193. ABA Chem Pharmaceutical Intermediates Product and Services
Table 194. ABA Chem Recent Developments
Table 195. Tianma Corporation Information
Table 196. Tianma Description and Overview
Table 197. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 198. Tianma Pharmaceutical Intermediates Product and Services
Table 199. Tianma Recent Developments
Table 200. Jiujiujiu Corporation Information
Table 201. Jiujiujiu Description and Overview
Table 202. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 203. Jiujiujiu Pharmaceutical Intermediates Product and Services
Table 204. Jiujiujiu Recent Developments
Table 205. Alpha Corporation Information
Table 206. Alpha Description and Overview
Table 207. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 208. Alpha Pharmaceutical Intermediates Product and Services
Table 209. Alpha Recent Developments
Table 210. Jiuzhou Corporation Information
Table 211. Jiuzhou Description and Overview
Table 212. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 213. Jiuzhou Pharmaceutical Intermediates Product and Services
Table 214. Jiuzhou Recent Developments
Table 215. Yongtai Corporation Information
Table 216. Yongtai Description and Overview
Table 217. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021)
Table 218. Yongtai Pharmaceutical Intermediates Product and Services
Table 219. Yongtai Recent Developments
Table 220. Key Raw Materials Lists
Table 221. Raw Materials Key Suppliers Lists
Table 222. Pharmaceutical Intermediates Distributors List
Table 223. Pharmaceutical Intermediates Customers List
Table 224. Research Programs/Design for This Report
Table 225. Key Data Information from Secondary Sources
Table 226. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Sales Market Share by Type in 2020 & 2027
Figure 3. GMP Picture
Figure 4. Non-GMP Picture
Figure 5. Global Pharmaceutical Intermediates Sales Market Share by Application in 2020 & 2027
Figure 6. Antibiotics Use Case
Figure 7. Antipyretic Analgesics Use Case
Figure 8. Vitamins Use Case
Figure 9. Others Use Case
Figure 10. Pharmaceutical Intermediates Report Years Considered
Figure 11. Global Pharmaceutical Intermediates Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pharmaceutical Intermediates Market Size 2016-2027 (US$ Million)
Figure 13. Global Pharmaceutical Intermediates Sales (2016-2021) & (K MT)
Figure 14. Global Pharmaceutical Intermediates Market Size Market Share by Region: 2020 VS 2027
Figure 15. Global Pharmaceutical Intermediates Sales Market Share by Region (2016-2021)
Figure 16. Global Pharmaceutical Intermediates Sales Market Share by Region in 2020
Figure 17. Global Pharmaceutical Intermediates Revenue Market Share by Region in 2016 VS 2020
Figure 18. Global Pharmaceutical Intermediates Sales Share by Manufacturers In 2020
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical Intermediates Sales in 2020
Figure 20. Pharmaceutical Intermediates Revenue Share by Manufacturers In 2020
Figure 21. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Pharmaceutical Intermediates Revenue Share by Type (2016-2021)
Figure 23. Global Pharmaceutical Intermediates Revenue Growth Rate by Type in 2016 & 2020
Figure 24. Global Pharmaceutical Intermediates Revenue Share by Application (2016-2021)
Figure 25. Global Pharmaceutical Intermediates Revenue Growth Rate by Application in 2016 & 2020
Figure 26. North America Pharmaceutical Intermediates Sales Market Share by Type (2016-2027)
Figure 27. North America Pharmaceutical Intermediates Revenue Market Share by Type (2016-2027)
Figure 28. North America Pharmaceutical Intermediates Sales Market Share by Application (2016-2027)
Figure 29. North America Pharmaceutical Intermediates Revenue Market Share by Application (2016-2027)
Figure 30. North America Pharmaceutical Intermediates Sales Share by Country (2016-2027)
Figure 31. North America Pharmaceutical Intermediates Revenue Share by Country (2016-2027)
Figure 32. U.S. Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 33. Canada Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 34. Europe Pharmaceutical Intermediates Sales Market Share by Type (2016-2027)
Figure 35. Europe Pharmaceutical Intermediates Revenue Market Share by Type (2016-2027)
Figure 36. Europe Pharmaceutical Intermediates Sales Market Share by Application (2016-2027)
Figure 37. Europe Pharmaceutical Intermediates Revenue Market Share by Application (2016-2027)
Figure 38. Europe Pharmaceutical Intermediates Sales Share by Country (2016-2027)
Figure 39. Europe Pharmaceutical Intermediates Revenue Share by Country (2016-2027)
Figure 40. Germany Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 41. France Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 42. U.K. Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 43. Italy Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 44. Russia Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 45. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Type (2016-2027)
Figure 46. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Type (2016-2027)
Figure 47. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Application (2016-2027)
Figure 48. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Application (2016-2027)
Figure 49. Asia Pacific Pharmaceutical Intermediates Sales Share by Region (2016-2027)
Figure 50. Asia Pacific Pharmaceutical Intermediates Revenue Share by Region (2016-2027)
Figure 51. China Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 52. Japan Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 53. South Korea Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 54. India Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 55. Australia Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 56. Taiwan Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 57. Indonesia Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 58. Thailand Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 59. Malaysia Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 60. Philippines Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 61. Vietnam Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 62. Latin America Pharmaceutical Intermediates Sales Market Share by Type (2016-2027)
Figure 63. Latin America Pharmaceutical Intermediates Revenue Market Share by Type (2016-2027)
Figure 64. Latin America Pharmaceutical Intermediates Sales Market Share by Application (2016-2027)
Figure 65. Latin America Pharmaceutical Intermediates Revenue Market Share by Application (2016-2027)
Figure 66. Latin America Pharmaceutical Intermediates Sales Share by Country (2016-2027)
Figure 67. Latin America Pharmaceutical Intermediates Revenue Share by Country (2016-2027)
Figure 68. Mexico Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 69. Brazil Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 70. Argentina Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 71. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Type (2016-2027)
Figure 72. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Type (2016-2027)
Figure 73. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Application (2016-2027)
Figure 74. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Application (2016-2027)
Figure 75. Middle East and Africa Pharmaceutical Intermediates Sales Share by Country (2016-2027)
Figure 76. Middle East and Africa Pharmaceutical Intermediates Revenue Share by Country (2016-2027)
Figure 77. Turkey Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 78. Saudi Arabia Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 79. U.A.E Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million)
Figure 80. Pharmaceutical Intermediates Value Chain
Figure 81. Pharmaceutical Intermediates Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Keyplayers in Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2021-2027
LonzaCatalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
Request Sample
Request Discount
